Substituted gamma lactams as therapeutic agents

Details for Australian Patent Application No. 2009239381 (hide)

Owner Allergan, Inc.

Inventors Dinh, Danny T.; Old, David W.

Agent Davies Collison Cave

Pub. Number AU-A-2009239381

PCT Pub. Number WO2009/132097

Priority 61/047,510 24.04.08 US

Filing date 22 April 2009

Wipo publication date 29 October 2009

International Classifications

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/132097 Priority application(s): WO2009/132097

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009239385-Methods of treating fungal infections

2009239379-Apparatus, and associated method, for facilitating access to a home, or other public network